Commissioner McCarty Appoints Eric Lingswiler as Interim Director of Life and Health Product Review

Aug 18, 2008

Florida Insurance Commissioner Kevin McCarty appointed Eric Lingswiler as Interim Director of Life and Health Product Review for the Florida Office of Insurance Regulation (“OIR”) on August 18, 2008. 

The OIR press release is reprinted below.


Should you have any questions or comments, please do not hesitate to contact Colodny Fass.


Florida Insurance Commissioner Names Eric Lingswiler Interim Director of Life and Health Product Review

TALLAHASSEE, Fla. – Florida Insurance Commissioner Kevin McCarty today announced that he has appointed Eric Lingswiler to the position of interim director of Life and Health Product Review. Mr. Lingswiler will report to Deputy Commissioner for Life and Health Mary Beth Senkewicz.

Mr. Lingswiler joined what was then the Department of Insurance in 1995 as a forms analyst in the Bureau of Life and Health Forms and Rates. Soon after, Mr. Lingswiler was promoted to supervisor of the unit.

In 2000, Mr. Lingswiler was asked to head the Specialty Insurers area that regulated the viatical settlement industry, eventually overseeing sweeping changes on both the regulatory and legislative fronts.

In 2003, Mr. Lingswiler switched to the property and casualty side in the new Office of Insurance Regulation (Office), taking on the duties of bureau chief of Property and Casualty Forms and Rates.

Mr. Lingswiler served in the above role until 2005 when he took on the duties of investigating unauthorized and unlicensed insurance companies. The role was expanded in 2007 to include Mr. Lingswiler’s current function as investigation manager of the Special Investigative Unit that works under the direct supervision of General Counsel Steve Parton.     

Mr. Lingswiler’s appointment is effective immediately. He replaces Monica Rutkowski, who has left the Office to pursue a new career opportunity.

The Office will be conducting a national search for a permanent replacement.


To unsubscribe from this newsletter, please send an e-mail to